{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:45:48Z","timestamp":1777927548812,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrence of genital warts remains a significant clinical challenge despite various treatment options. Systemic inflammatory indices derived from routine blood counts, such as the systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), have recently been investigated as potential prognostic markers in HPV-related diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 217 male patients who underwent electrocauterisation for penoscrotal warts between March and September 2024. Patients were classified as having primary or recurrent lesions at presentation. Preoperative neutrophil, lymphocyte, and platelet counts were used to calculate inflammatory indices, and their associations with recurrence were analysed. Primary patients were also followed for 6\u00a0months to assess post-treatment recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Recurrent cases (44.2%) exhibited significantly higher SII, NLR, and PLR values compared with primary cases (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.004,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.011, and\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.047, respectively). Smoking prevalence was greater among recurrent patients (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.008). Among primary patients, those who experienced recurrence at 6\u00a0months had higher SII (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.006) and NLR (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.014). Multivariate analysis identified SII as an independent predictor of recurrence (OR = 1.42, 95% CI 1.08\u20131.91,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.027).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated SII and NLR levels are associated with an increased risk of genital wart recurrence, and SII independently predicts recurrence among primary cases. These inexpensive and readily available markers may aid in recurrence risk stratification and follow-up planning. Longer prospective studies incorporating HPV genotyping and behavioural risk factors are warranted to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09564624251390666","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:17:46Z","timestamp":1760642266000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Can inflammation predict recurrence? A study on genital warts in men"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-1027","authenticated-orcid":false,"given":"Mertcan","family":"Dama","sequence":"first","affiliation":[{"name":"Ministry of Health Izmir City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1603-3336","authenticated-orcid":false,"given":"An\u0131l","family":"Eker","sequence":"additional","affiliation":[{"name":"Ministry of Health Izmir City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9582-3370","authenticated-orcid":false,"given":"\u0130smail","family":"Ba\u015faran","sequence":"additional","affiliation":[{"name":"Ministry of Health Izmir City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tansu","family":"De\u011firmenci","sequence":"additional","affiliation":[{"name":"Ministry of Health Izmir City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06470-x"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7184.85409"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e318286bb53"},{"issue":"2","key":"e_1_3_5_5_2","first-page":"129","article-title":"High-risk human papilloma virus infection determined by hybrid capture II assay in a Turkish university hospital outpatient clinic","volume":"12","author":"Tuncer S","year":"2006","unstructured":"Tuncer S, Ba\u015faran M, Usta\u00e7elebi \u015e, et al. High-risk human papilloma virus infection determined by hybrid capture II assay in a Turkish university hospital outpatient clinic. Gynecol Obstet Reprod Med 2006; 12(2): 129\u2013134.","journal-title":"Gynecol Obstet Reprod Med"},{"issue":"5","key":"e_1_3_5_6_2","first-page":"D1","article-title":"GAVI report","volume":"30","author":"de Sanjos\u00e9 S","year":"2012","unstructured":"de Sanjos\u00e9 S, Brotons M, Castellsagu\u00e9 X, et al. GAVI report. Vaccine 2012; 30(Suppl 5): D1\u2013D83.","journal-title":"Vaccine"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1822"},{"key":"e_1_3_5_8_2","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem: technology landscape","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem: technology landscape. WHO, 2020."},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.006"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.09.002"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/597071"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2017.08.015"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3182215512"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.3.371"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-008-0302-z"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21009"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4020260"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15570"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28666"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000292372"},{"issue":"11","key":"e_1_3_5_21_2","first-page":"1571","article-title":"State-level disparities in cervical cancer prevention and outcomes in the US: a modeling study","volume":"116","author":"Alarid-Escudero F","year":"2024","unstructured":"Alarid-Escudero F, Gracia V, Wolf M, et al. State-level disparities in cervical cancer prevention and outcomes in the US: a modeling study. J Natl Cancer Inst 2024; 116(11): 1571\u20131582.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462420950562"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01157-9"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12561-7"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S485698"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62342-2"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq015"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/596758"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32831a7246"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2425535"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.07.008"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.4.789"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09375.x"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251390666","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624251390666","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251390666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:47:14Z","timestamp":1777675634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624251390666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/09564624251390666"],"URL":"https:\/\/doi.org\/10.1177\/09564624251390666","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}